
|Articles|November 6, 2015
Pediatric Drug Development & Therapeutics in October TIRS
Author(s)DIA
Advertisement
The Special Section on Pediatric Therapeutics in the November, 2015 issue of
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Generates $1.5 Billion Stockpile of Orforglipron Ahead of FDA Decision
2
Pharmaceutical Executive Daily: Eli Lilly's $1.5 Billion Stockpile of Orforglipron
3
Pharm Exec's 2026 Pipeline Report: Next Frontiers in Focus
4
Bridging the Data Gap: How Digital Behavioral Insights Can Transform HCP Targeting in Specialty Care
5




